BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/31/2024 7:20:10 AM | Browse: 546 | Download: 874
Publication Name World Journal of Transplantation
Manuscript ID 96225
Country India
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Minireviews
Article Title Tuberculosis in kidney transplant candidates and recipients
Manuscript Source Invited Manuscript
All Author List Pallavi Prasad, Sourabh Sharma, Subashri Mohanasundaram, Anupam Agarwal and Himanshu Verma
ORCID
Author(s) ORCID Number
Pallavi Prasad http://orcid.org/0000-0002-2770-306x
Sourabh Sharma http://orcid.org/0000-0003-2513-5131
Subashri Mohanasundaram http://orcid.org/0009-0003-9035-2068
Funding Agency and Grant Number
Corresponding Author Pallavi Prasad, Visiting Professor, MBBS, MD, Assistant Professor, Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar East, Near AIIMS metro station, New Delhi 110029, Delhi, India. pallaviprasad1986@gmail.com
Key Words Tuberculosis; Latent; Antitubercular therapy; Kidney transplantation; Donor; Interferon-gamma release assays; Tuberculin; Rifampicin; Isoniazid
Core Tip The management of tuberculosis (TB) in transplant candidates and recipients is evolving rapidly. The use of new techniques for detecting TB infection (TBI) and the adoption of TBI screening by developing countries is bringing the world close to the World Health Organization's goal of ending the TB epidemic by 2030. Literature regarding the acceptance of candidates and donors after intensive phase antitubercular therapy (ATT) is now available. Fluoroquinolone-based nonrifamycin ATT has shown excellent results in transplant recipients. The review incorporates the latest guidelines and gives an overview of current evidence in the field of TB in kidney transplantation with a glimpse into the future of this field.
Publish Date 2024-07-31 07:20
Citation

Prasad P, Sharma S, Mohanasundaram S, Agarwal A, Verma H. Tuberculosis in kidney transplant candidates and recipients. World J Transplant 2024; 14(3): 96225

URL https://www.wjgnet.com/2220-3230/full/v14/i3/96225.htm
DOI https://dx.doi.org/10.5500/wjt.v14.i3.96225
Full Article (PDF) WJT-14-96225-with-cover.pdf